These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9886407

  • 1. Redirecting effector T cells through their IL-2 receptors.
    Lustgarten J, Marks J, Sherman LA.
    J Immunol; 1999 Jan 01; 162(1):359-65. PubMed ID: 9886407
    [Abstract] [Full Text] [Related]

  • 2. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS, Penichet ML, Morrison SL.
    J Immunol; 1999 Jul 01; 163(1):250-8. PubMed ID: 10384123
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.
    Gritzapis AD, Mahaira LG, Perez SA, Cacoullos NT, Papamichail M, Baxevanis CN.
    Cancer Res; 2006 May 15; 66(10):5452-60. PubMed ID: 16707474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abdulsamad K, Adams SL.
    Immunol Invest; 2008 May 15; 37(4):315-38. PubMed ID: 18569073
    [Abstract] [Full Text] [Related]

  • 8. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H, Hu HM, Urba WJ, Fox BA.
    J Immunol; 1999 Oct 15; 163(8):4462-72. PubMed ID: 10510388
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
    Efferson CL, Kawano K, Tsuda N, Palese P, García-Sastre A, Ioannides CG.
    Anticancer Res; 2005 Oct 15; 25(2A):715-24. PubMed ID: 15868901
    [Abstract] [Full Text] [Related]

  • 10. Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication.
    Lustgarten J.
    Cancer Immunol Immunother; 2003 Dec 15; 52(12):751-60. PubMed ID: 12827309
    [Abstract] [Full Text] [Related]

  • 11. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
    Hess AD, Thoburn C, Chen W, Miura Y, Van der Wall E.
    Clin Immunol; 2001 Oct 15; 101(1):67-76. PubMed ID: 11580228
    [Abstract] [Full Text] [Related]

  • 12. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    Altenschmidt U, Kahl R, Moritz D, Schnierle BS, Gerstmayer B, Wels W, Groner B.
    Clin Cancer Res; 1996 Jun 15; 2(6):1001-8. PubMed ID: 9816261
    [Abstract] [Full Text] [Related]

  • 13. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.
    Yoon SH, Lee JM, Cho HI, Kim EK, Kim HS, Park MY, Kim TG.
    Cancer Gene Ther; 2009 Jun 01; 16(6):489-97. PubMed ID: 19096447
    [Abstract] [Full Text] [Related]

  • 16. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA, Schlom J, Abrams SI.
    Cell Immunol; 1999 May 25; 194(1):78-89. PubMed ID: 10357883
    [Abstract] [Full Text] [Related]

  • 17. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.
    Weijtens ME, Willemsen RA, Valerio D, Stam K, Bolhuis RL.
    J Immunol; 1996 Jul 15; 157(2):836-43. PubMed ID: 8752936
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothée G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S.
    Cancer; 2001 Jan 01; 91(1):113-22. PubMed ID: 11148567
    [Abstract] [Full Text] [Related]

  • 19. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T, Wall EM, Milne K, Theiss P, Watson P, Nelson BH.
    Clin Cancer Res; 2007 Dec 01; 13(23):7172-80. PubMed ID: 18056198
    [Abstract] [Full Text] [Related]

  • 20. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.